Simcere Pharmaceutical Group Reports Third Quarter 20...( borrowings 33...),Health

borrowings 333,000 19,000 2,536

Accounts and bills payable 20,089 14,996 2,001

Accrued payroll and

employee benefits 23,766 25,628 3,420

Other payables and accrued

liabilities 169,874 244,029 32,569

Amounts due to related

parties 1,352 1,216 162

Income taxes payable 20,092 17,196 2,295

Total current liabilities 568,173 322,065 42,983

Deferred income taxes 23,634 25,177 3,360

Total liabilities 591,807 347,242 46,343

Minority interests -- 1,919 256

Shareholders' equity

Contributed capital 7,909 9,839 1,313

Additional paid-in capital 265,964 1,541,755 205,765

Accumulated other

comprehensive loss -- (27,039) (3,609)

Retained earnings 168,867 392,056 52,324

Total shareholders' equity 442,740 1,916,611 255,795

Commitments and

contingencies

Total liabilities, minority

interests and

shareholders' equity 1,034,547 2,265,772 302,393

Note: The conversions of Renminbi (RMB) into United States dollars (USD)

as at the reporting dates are based on the noon buying rate of

USD1.00 = RMB7.4928 on September 28, 2007 in The City of New York

for cable transfers of Renminbi as certified for customs purposes

by the Federal Reserve. No representation is intended to imply

that the RMB amounts could have been, or could be, converted,

realized or settled into U.S. dollars at that rate on the<
'/>"/>